PolicyView™ is an iPad and iPhone compatible app that houses a comprehensive library of reimbursement policies for Specialty Drugs across leading national and regional payers in the US.
PolicyView™ provides direct access to thousands of Medical Policies and Prior Authorization Forms for Autoimmune and Oncology therapeutic agents.
PolicyView™ captures the key criteria for authorization and utilization of drugs in Rheumatoid Arthritis, Psoriasis, Multiple Sclerosis, Crohn’s/Ulcerative Colitis, Lupus, and Oncology (including Breast Cancer, Colorectal Cancer, Prostate Cancer, Lung Cancer, Metastatic Melanoma, Renal Cell Cancer, Multiple Myeloma, CML, and CLL).
PolicyView’s analysis and query functions lets you access the most up-to-date coverage policies for specialty brands so you can:
- Track trends in payer coverage policies by category over time
- Quickly and efficiently source medical policy data without the cumbersome searching across insurer websites
- Create customized therapeutic area and/or drug reports based on key metrics e.g. formulary tier, required testing, and step criteria
Pharmspective’s ongoing surveillance of payer policies gives subscribers confidence that they have the most recent reimbursement criteria representing the majority of total insured lives in the U.S.